Your browser doesn't support javascript.
loading
Ketamine Use in the Intubation of Critically Ill Children with Neurological Indications: A Multicenter Retrospective Analysis.
Loi, Mervin V; Lee, Jan Hau; Huh, Jimmy W; Mallory, Palen; Napolitano, Natalie; Shults, Justine; Krawiec, Conrad; Shenoi, Asha; Polikoff, Lee; Al-Subu, Awni; Sanders, Ronald; Toal, Megan; Branca, Aline; Glater-Welt, Lily; Ducharme-Crevier, Laurence; Breuer, Ryan; Parsons, Simon; Harwayne-Gidansky, Ilana; Kelly, Serena; Motomura, Makoto; Gladen, Kelsey; Pinto, Matthew; Giuliano, John; Bysani, Gokul; Berkenbosch, John; Biagas, Katherine; Rehder, Kyle; Kasagi, Mioko; Lee, Anthony; Jung, Philipp; Shetty, Rakshay; Nadkarni, Vinay; Nishisaki, Akira.
Afiliação
  • Loi MV; Department of Pediatric Subspecialties, Children's Intensive Care Unit, KK Women's and Children's Hospital, 100 Bukit Timah Road, Singapore, Singapore. mervin.loi.v.t@singhealth.com.sg.
  • Lee JH; Department of Pediatric Subspecialties, Children's Intensive Care Unit, KK Women's and Children's Hospital, 100 Bukit Timah Road, Singapore, Singapore.
  • Huh JW; Department of Anesthesiology and Critical Care Medicine, Children's Hospital of Philadelphia and University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Mallory P; Department of Pediatric Critical Care Medicine, Duke Children's Hospital and Health Center, Durham, NC, USA.
  • Napolitano N; Respiratory Therapy Department, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Shults J; Department of Biostatistics, Children's Hospital of Philadelphia and University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Krawiec C; Departments of Pediatric Critical Care Medicine and Pediatrics, Penn State Health Children's Hospital, Hershey, PA, USA.
  • Shenoi A; Department of Pediatrics, University of Kentucky, Lexington, KY, USA.
  • Polikoff L; Department of Pediatric Critical Medicine, Warren Alpert Medical School of Brown University, Providence, RI, USA.
  • Al-Subu A; Division of Pediatric Critical Care Medicine, Department of Pediatrics, University of Wisconsin, School of Medicine and Public Health, Madison, WI, USA.
  • Sanders R; Division of Critical Care Medicine, Arkansas Children's Hospital, Little Rock, AR, USA.
  • Toal M; Division of Pediatric Critical Care Medicine, Department of Pediatrics, Weill Cornell Medicine, New York, NY, USA.
  • Branca A; Department of Pediatric Critical Care Medicine, Phoenix Children's Hospital, Phoenix, AZ, USA.
  • Glater-Welt L; Department of Pediatric Critical Care Medicine, Cohen Children's Medical Center of New York, New Hyde Park, NY, USA.
  • Ducharme-Crevier L; Division of Pediatric Critical Care Medicine, Department of Pediatrics, Centre Hospitalier Universitaire Sainte-Justine, Montreal, Canada.
  • Breuer R; Division of Critical Care Medicine, Department of Pediatrics, John R. Oishei Children's Hospital, Buffalo, NY, USA.
  • Parsons S; Section of Critical Care Medicine, Alberta Children's Hospital, Calgary, Canada.
  • Harwayne-Gidansky I; Division of Pediatric Critical Care Medicine, Department of Pediatrics, Albany Medical College, Albany, NY, USA.
  • Kelly S; Division of Pediatric Critical Care Medicine, Department of Pediatrics, Oregon Health and Science University Doernbecher Children's Hospital, Portland, OR, USA.
  • Motomura M; Division of Pediatric Critical Care Medicine, Aichi Children's Health and Medical Center, Aichi, Japan.
  • Gladen K; Department of Pediatric Critical Care Medicine, Phoenix Children's Hospital, Phoenix, AZ, USA.
  • Pinto M; Department of Pediatrics, New York Medical College, Valhalla, NY, USA.
  • Giuliano J; Section of Pediatric Critical Care, Department of Pediatrics, Yale University School of Medicine, New Haven, CT, USA.
  • Bysani G; Department of Pediatrics, Medical City Children's Hospital, Dallas, TX, USA.
  • Berkenbosch J; Department of Pediatric Critical Care, University of Louisville and Norton Children's Hospital, Louisville, KY, USA.
  • Biagas K; Division of Pediatric Critical Care Medicine, Department of Pediatrics, Renaissance School of Medicine at Stony, Brook University, Stony Brook, NY, USA.
  • Rehder K; Division of Pediatric Critical Care, Duke Children's Hospital, Durham, NC, USA.
  • Kasagi M; Division of Pediatric Critical Care Medicine, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.
  • Lee A; Division of Critical Care Medicine, Nationwide Children's Hospital, Columbus, OH, USA.
  • Jung P; Department of Pediatrics, University Hospital Schleswig-Holstein, Campus Luebeck, Luebeck, Germany.
  • Shetty R; Pediatric Intensive Care, Rainbow Children's Hospital, Bengaluru, India.
  • Nadkarni V; Department of Anesthesiology and Critical Care Medicine, Children's Hospital of Philadelphia and University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Nishisaki A; Department of Anesthesiology and Critical Care Medicine, Children's Hospital of Philadelphia and University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Neurocrit Care ; 40(1): 205-214, 2024 Feb.
Article em En | MEDLINE | ID: mdl-37160847
ABSTRACT

BACKGROUND:

Ketamine has traditionally been avoided for tracheal intubations (TIs) in patients with acute neurological conditions. We evaluate its current usage pattern in these patients and any associated adverse events.

METHODS:

We conducted a retrospective observational cohort study of critically ill children undergoing TI for neurological indications in 53 international pediatric intensive care units and emergency departments. We screened all intubations from 2014 to 2020 entered into the multicenter National Emergency Airway Registry for Children (NEAR4KIDS) registry database. Patients were included if they were under the age of 18 years and underwent TI for a primary neurological indication. Usage patterns and reported periprocedural composite adverse outcomes (hypoxemia < 80%, hypotension/hypertension, cardiac arrest, and dysrhythmia) were noted.

RESULTS:

Of 21,562 TIs, 2,073 (9.6%) were performed for a primary neurological indication, including 190 for traumatic brain injury/trauma. Patients received ketamine in 495 TIs (23.9%), which increased from 10% in 2014 to 41% in 2020 (p < 0.001). Ketamine use was associated with a coindication of respiratory failure, difficult airway history, and use of vagolytic agents, apneic oxygenation, and video laryngoscopy. Composite adverse outcomes were reported in 289 (13.9%) Tis and were more common in the ketamine group (17.0% vs. 13.0%, p = 0.026). After adjusting for location, patient age and codiagnoses, the presence of respiratory failure and shock, difficult airway history, provider demographics, intubating device, and the use of apneic oxygenation, vagolytic agents, and neuromuscular blockade, ketamine use was not significantly associated with increased composite adverse outcomes (adjusted odds ratio 1.34, 95% confidence interval CI 0.99-1.81, p = 0.057). This paucity of association remained even when only neurotrauma intubations were considered (10.6% vs. 7.7%, p = 0.528).

CONCLUSIONS:

This retrospective cohort study did not demonstrate an association between procedural ketamine use and increased risk of peri-intubation hypoxemia and hemodynamic instability in patients intubated for neurological indications.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Insuficiência Respiratória / Ketamina Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Adolescent / Child / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Insuficiência Respiratória / Ketamina Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Adolescent / Child / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article